Perhaps in the real world also, we could now eat to our heart's content without compromising on our health and good looks. Mice with an extra dose of a known anti-cancer gene lose weight even as their appetites grow. Not only that, but according to the report in the March issue of the Cell Press journal Cell Metabolism, the animals also live longer, and that isn't just because they aren't getting cancer, either.
One of the animals' youthful secrets is hyperactive brown fat, which burns energy instead of storing it. The findings add to evidence that tumor suppressors aren't designed only to protect us against cancer, the researchers say. They also point to new treatment strategies aimed to boost brown fat and fight aging.
Brown Fat to Fight Flab
Around 50 grams of white fat stores 300 kilocalories. In contrast the same amount of brown fat burns 300 kilocalories a day. Such is the magic of this good fat.
Advertisement
"Tumor suppressors are actually genes that have been used by evolution to protect us from all kinds of abnormalities," said Manuel Serrano of the Spanish National Cancer Research Center.
In this case, the researchers studied a tumor suppressor commonly lost in human cancers. Mice with an extra copy of the gene known as Pten didn't get cancer, but that's not the half of it. Those mice were also leaner, even as they ate more than controls, Serrano said. That suggested that the animals were experiencing some sort of metabolic imbalance—and a beneficial one at that.
![Stroke]( "Stroke")
Stroke can cause permanent disability and it is important to recognize its early warning signs to stop its progress. Early warning signs of stroke include sudden weakness of facial muscles.
Cancer protection aside, the animals lived longer than usual. They were also less prone to insulin resistance and had less fat in their livers. Those benefits seem to trace back to the fact that those Pten mice were burning more calories thanks to overactive brown fat. Studies in isolated brown fat cells confirmed that a boost in Pten increases the activity of those cells. Pten also made it easier for brown fat to form.
"This tumor suppressor protects against metabolic damage associated with aging by turning on brown fat," Serrano says.
A small compound inhibitor that mimics the effects of Pten also came with those varied benefits. That's encouraging news for the prospect of finding a drug that might do for us what the extra Pten gene did for the mice.
After all, Serrano said, humans were built for a time when 30 would have been considered old age. "We're well protected against cancer and cardiovascular disease" early in life. As it has become commonplace to live to the age of 80, we could all use a little help.
Source: Eurekalert
Stroke
Stroke can cause permanent disability and it is important to recognize its early warning signs to stop its progress. Early warning signs of stroke include sudden weakness of facial muscles.
Advertisement
Cancer protection aside, the animals lived longer than usual. They were also less prone to insulin resistance and had less fat in their livers. Those benefits seem to trace back to the fact that those Pten mice were burning more calories thanks to overactive brown fat. Studies in isolated brown fat cells confirmed that a boost in Pten increases the activity of those cells. Pten also made it easier for brown fat to form.
"This tumor suppressor protects against metabolic damage associated with aging by turning on brown fat," Serrano says.
A small compound inhibitor that mimics the effects of Pten also came with those varied benefits. That's encouraging news for the prospect of finding a drug that might do for us what the extra Pten gene did for the mice.
After all, Serrano said, humans were built for a time when 30 would have been considered old age. "We're well protected against cancer and cardiovascular disease" early in life. As it has become commonplace to live to the age of 80, we could all use a little help.
Source: Eurekalert
Heart Attack- Lifestyle risks
Heart attack is the death of the heart muscle due to loss of blood supply. Simple guidelines to avoid heart attack are listed.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
A ray of hope for glioma patients as targeted therapy boosts treatment duration.